Home » DiaSorin, double-digit growth also in 2021

DiaSorin, double-digit growth also in 2021

by admin

Diasorin closed the first quarter with strong growth results (still supported by test sales for Coronavirus but also supported by the recovery of ex-Covid revenues) and looks confidently at visibility for the rest of the year, releasing a guidance that foresees double-digit growth, with a wide range (15-25%) linked to the uncertainties on the effects of the vaccination plan and on the evolution of the pandemic situation.

In the first part of the year the group recorded a net profit …

See also  Real estate debt crisis is more than experts: China's real estate bubble is tricky | China Economy | Evergrande

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy